The State of Longevity 2021
By Daragh Campbell 2021 demonstrated that research into antiaging therapies is going from strength-to-strength, and our review of longevity clinical trials shows this clearly. As different areas of research continue to gain traction (cellular reprogramming, in particular), we wanted to analyse exactly how the longevity clinical trial market performed last year. In order to assess clinical trial data across 2021, we interrogated the Longevity.Technology database, which consists of over 250 longevity companies (and growing all the time!). This was used to...